Pilot the $129 anchor with new annual-plan buyers before changing public pricing.
The price increase has credible upside for ROI-led buyers, but current evidence does not support a broad public rollout.
Start with the loaded example or enter your own decision. No login is required; sign in only to save private history.
Source boundary: example responses are synthetic hypotheses, not customer research or promises of future behavior.
Structuring the brief and its evidence boundary.
The price increase has credible upside for ROI-led buyers, but current evidence does not support a broad public rollout.
Custom instruction
Facts, supplied evidence, model assumptions, weak claims, and missing information remain separate.
This is the highest-value evidence gap because it can reverse the recommendation.
Relevance is a modeling weight, not a claim about real market share. All example segments are fictional.
Ranges show uncertainty within each branch. Branches are mutually exclusive descriptions of the rollout outcome.
Lower upside, higher reversibility, and a smaller evidence requirement.
This preview adjusts the displayed scenario model only. Rerun after editing the underlying evidence.
The price increase has credible upside for ROI-led buyers, but current evidence does not support a broad public rollout.